Industry Insights: Health and Climate - The Biopharmaceutical Industry’s Challenge of Carbon Neutrality

As the biopharmaceutical and biotechnology sectors are looking to tackle environmental challenges, VERDOT is taking a proactive approach to reduce their carbon footprint. Through the M.E.R.C.I methodology, VERDOT prioritizes eco-design and strategic partnerships, such as the collaboration with Stock CO2, to merge technology and sustainability.